CT-guided 125I seed implantation for treating abdominal metastatic lymph nodes
10.13929/j.1672-8475.201711027
- VernacularTitle:CT引导下经皮125I粒子植入治疗腹部转移性淋巴结
- Author:
Jie ZHANG
1
;
Dong LU
;
Nan ZHU
;
Fu Wei LYU
;
Yongqiang YU
Author Information
1. 安徽医科大学附属安徽省立医院介入放射科
- Keywords:
Lymph nodes;
Neoplasm metastasis;
Brachytherapy;
Tomography,X-ray computed
- From:
Chinese Journal of Interventional Imaging and Therapy
2018;15(3):129-133
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and efficacy of CT-guided 125I seed implantation in the treatment of metastatic lymph nodes within the abdomen.Methods Data of 55 patients who underwent CT-guided 125I seed implantation with a total of 63 metastatic lymph nodes within the abdomen were retrospectively analyzed.The efficacy was evaluated.Results 125I seeds were successfully implanted in all 55 patients,and the radiation dose reached the pre-operation plan requirements.The response rate of 1,3,6,9 and 12 months after operation was 76.19% (48/63),80.65% (50/62),71.43%(30/42),77.50%(31/40) and 78.95%(30/38),respectively.And the clinical benefit rate was 93.65%(59/63),88.71%(55/62),80.95 % (34/42),85.00%(34/40) and 84.21%(32/38),respectively.There were 42 patients combined with abdominal pain and back pain before the operation.Among them,39 patients (39/42,92.86%) relieved 1 month after operation.No severe complication occurred intraoperatively or postoperatively,such as inhibition of bone marrow,bleeding or infection.The survival rate of 1,3,6,9 and 12 months postoperatively was 100%,98.20%,61.80%,58.20% and 54.50%,respectively.Conclusion CT-guided 125I seed implantation is one of the safe and effective methods for treating metastatic lymph nodes within the abdomen.